BioCryst Pharmaceuticals Inc Sustainability Reports
BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes, and develops novel small-molecule medicines for hereditary angioedema and other rare diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z0INP1Z5NP6J59
FIGI: BBG001S7K151
4 reports from 2010 to 2025
